P\S\L Names Warth as Instar MD for Europe

In London, healthcare research specialist P\S\L Group has appointed Kelly Warth as Managing Director, Europe of its healthcare tracking and testing business Instar.

Instar offers custom-assembled virtual panels and proprietary advanced analytics techniques to enable clients to test, track and enhance the elements that drive a brand's performance. Warth (pictured) has held numerous senior positions both agency and client side. Most recently, she worked for GfK as UK Head of Health & Global Business Development, having previously been the firm's Director & Head of Health in Sydney, Australia. Prior to this, she was Senior Market Insights Manager at Pfizer, a Senior Account Manager at boutique agency Ruby Cha Cha, Research Officer for the National Prescribing Service, and Healthcare Account Manager at Jigsaw Strategic Research. She began her research career as an RE at Dendrite (later acquired by Cegedim Strategic Data).

Commenting on the appointment, Jean-Olivier Marty, Group President of Instar, said: 'Kelly will be instrumental in further developing our successful partnerships with pharmaceutical clients in Europe. Her intimate knowledge of market research and clients' needs will allow us to keep providing innovative best in class tracking and testing research, allowing our clients to truly enhance the performance of their brands'.

Web sites: www.pslgroup.com and www.instarresearch.com .